Sign In to Follow Application
View All Documents & Correspondence

Beverage Precursor And Process For The Manufacture Thereof

Abstract: The present invention provides a beverage precursor comprising black leaf tea characterised in that the precursor comprises theanine in an amount of at least 4% by dry weight of the precursor. The invention also provides a process for manufacturing a beverage precursor wherein black tea is coated with theanine and then blended with uncoated tea.

Get Free WhatsApp Updates!
Notices, Deadlines & Correspondence

Patent Information

Application #
Filing Date
03 March 2010
Publication Number
31/2010
Publication Type
INA
Invention Field
FOOD
Status
Email
Parent Application
Patent Number
Legal Status
Grant Date
2016-02-02
Renewal Date

Applicants

HINDUSTAN UNILEVER LIMITED
165/166 BACKBAY RECLAMATION, MUMBAI - 400020, MAHARASHTRA, INDIA.

Inventors

1. SMITH LAN
UNILEVER R&D COLWORTH, SHARNBROOK, BEDFORDSHIRE MK 44 1LQ, UNITED KINGDOM.

Specification

FORM - 2
THE PATENTS ACT, 1970
(39 of 1970) &
The Patents Rules, 2003
COMPLETE SPECIFICATION
(See Section 10 and Rule 13)
BEVERAGE PRECURSOR AND PROCESS FOR THE MANUFACTURE THEREOF
HINDUSTAN UNILEVER LIMITED, a company incorporated under the Indian Companies Act, 1913 and having its registered office at 165/166, Backbay Reclamation, Mumbai -400 020, Maharashtra, India
The following specification particularly describes the invention and the manner in which it is to be performed
BEVERAGE PRECURSOR AND PROCESS FOR THE MANUFACTURE THEREOF TECHNICAL FIELD OF THE INVENTION
The present invention relates to a beverage precursor comprising black leaf tea. The present invention also relates to a process for manufacturing beverage precursors comprising black leaf tea.
BACKGROUND TO THE INVENTION
Generally, to prepare black leaf tea, fresh green leaves of the plant Camellia sinensis are withered (a process to allow the plucked tea leaves to lose moisture and bring about chemical / biochemical changes especially in aroma)r macerated, fermented (in which process enzymes in the tea leaf use atmospheric oxygen to oxidise various substrates to produce coloured products) and then dried at high temperature (to inactivate the enzymes). Green tea manufacture does not involve a fermentation process although partial fermentation may be used to produce intermediate-type teas known as "oolong" tea.
Tea may be consumed as a hot beverage or as a cold beverage (for example iced tea). The numerous compounds in the leaves that give the beverage its unique organoleptic properties are only sparingly soluble in cold water therefore tea is usually infused in water at temperatures close to 100°C.
Cold water soluble teas are usually prepared by spray drying the liquor obtained by extraction of black tea. However, this process requires high temperatures or treatment with harsh chemicals such as alkalis, which adversely affect tea attributes including taste, colour and flavour.
WO 2005/067727 (Unilever PLC et al.) concerns a process for the manufacture of a tea product which is readily infusible and has improved red colour. The process comprises contacting black tea with ascorbic acid and/or its salts, an oxidizing agent and water for a period of at least 5 minutes followed by drying. The teas have a good red colour. The publication also teaches that the black tea is preferably additionally contacted with one or more amino acids prior to drying. Despite the fact that the technology disclosed in WO 2005/067727 represents a significant improvement in producing black leaf teas that infuse rapidly and have good red colour, there is a need to produce teas with good infusion performance using compounds naturally associated with tea. Consumers are increasingly looking for products with a perceived natural image and are particularly wary of products containing ingredients which may be perceived as artificial additives.
Theanine is an amino acid which, within the plant kingdom, is uniquely found in tea (Camellia sinensis) and comprises about 1% by weight of dry material in tea leaves.
We have now found that compounding specific levels of theanine with black tea can produce a composition with improved infusion performance without the need to oxidise the theanine and/or react it with ascorbic acid.
DEFINITIONS
Beverage
As used herein the term "beverage" refers to a substantially aqueous drinkable composition suitable for human consumption.
Beverage Precursor
A beverage precursor is defined as a fabricated composition suitable for preparing a beverage.
Tea
"Tea" for the purposes of the present invention means material from Camellia sinensis var. Sinensis and/or Camellia sinensis var. Assamica.
"Leaf tea" for the purposes of this invention means tea leaves or a mixture of tea leaves and tea stem in an uninfused form. Where the leaf tea comprises stem it is preferred that the amount of stem is kept to a minimum as tea leaves produce a higher quality beverage than stem. Thus it is preferred that the leaf tea comprises at least 50% by weight of tea leaves, more preferably at least 70% and most preferably from 80 to 100%.
"Black leaf tea" refers to substantially fermented leaf tea.
"Fermentation" refers to the oxidative and hydrolytic process that tea undergoes when certain endogenous enzymes and substrates are brought together, e.g., by mechanical disruption of the cells by maceration of the leaves. During this process colourless catechins in the leaves are converted to a complex mixture of yellow and orange to dark-brown polyphenolic substances.
Coating
Where a leaf tea is described as "coated" with a substance, it should be understood that this means that the substance is exogenous to the leaf tea but has been combined with leaf tea in such a manner that it is cohesive therewith. Thus, whilst at least some of the substance coating the leaf tea may be (and preferably is) on the surface of the leaf tea, the term "coating" also encompasses absorbing the substance into the leaf tea.
SUMMARY OF THE INVENTION
In a first aspect, the present invention provides a beverage precursor comprising black leaf tea wherein the precursor comprises theanine in an amount of at least 4% by dry weight of the precursor.
We have found that precursors with relatively high levels of theanine have improved infusion performance compared to precursors having theanine levels typical of black leaf tea alone. Without wishing to be bound by theory, we believe that theanine may help to solubilise the coloured polyphenol fraction (e.g. theaflavin and/or thearubigin) of black tea.
We have also found that theanine may be absorbed onto black tea in very high amounts, making it possible to manufacture black tea coated with a high level of theanine. Furthermore, this coated black tea can be blended with uncoated tea to improve the infusion performance thereof.
Thus in second aspect, the present invention provides a process for manufacturing a beverage precursor, the process comprising the steps of:
i) coating black leaf tea with a composition comprising theanine to yield coated black leaf tea comprising at least 8% theanine by dry weight of the coated black tea; and then
ii) blending the coated black leaf tea with uncoated leaf tea.
Although any suitable process may be used to manufacture the beverage precursor of the first aspect, advantageously the process of the second aspect may be used. Thus the present invention also provides the beverage precursor of the first aspect obtained and/or obtainable by the process of the second aspect.
DETAILED DESCRIPTION
Beverage Precursor Theanine:
The precursor comprises at least 4% theanine by dry weight. In order to further enhance the infusion performance of the black tea, it is preferred that the precursor comprises theanine in an amount of at least 6%, more preferably at least 8%, more preferably still at least 12% and most preferably at least 20% by dry weight of the precursor. To retain the familiar properties of black tea, however, it is preferred that the level of theanine is not too high. Thus it is preferred that the amount of theanine is less than 50%, more preferably less than 40% and most preferably less than 35% by dry weight of the precursor.
It is preferred that the theanine is in the L-form because L- theanine is the naturally occurring isomer. Thus it is preferred that at least 90% of the theanine is L-theanine, more preferably at least 95% and most preferably from 98 to 100%.
Some of the theanine will usually be naturally present in the black leaf tea. However, in order to obtain the high levels required to enhance infusion performance the precursor will usually comprise added theanine, i.e. theanine exogenous to the black leaf tea. Typically the amount of added theanine will make up at least 75% of the total theanine in the precursor, more preferably at least 85%, more preferably still at least 90% and most preferably from 95 to 100%. The added theanine may comprise synthetic theanine, such as Sun theanine™ from the Taiyo Corporation. Alternatively or additionally the added theanine may be part of a tea extract, especially a tea extract naturally enriched in theanine such as those described in international patent applications WO 2006/021317, WO 2006/037503, WO 2006/037511 and/or WO 2006/037504, which are hereby incorporated by reference in their entirety.
Black leaf tea:
In order to maximise the familiar organoleptic properties of black tea it is preferred that the beverage precursor comprises black leaf tea in an amount of at least 60% by dry weight of the precursor, more preferably at least 70% and most preferably from 80 to 96%.
The black leaf tea may conveniently act as a carrier for added theanine. Thus in a preferred embodiment at least some of the black leaf tea is coated with at least some of the theanine. For example, at least 75% of the total theanine in the precursor may be coated on at least some of the black leaf tea, more preferably at least 85%, more preferably still at least 90% and most preferably from 95 to 100%. Especially preferred is that substantially all of the added theanine is coated on at least some of the black leaf tea.
All of the black leaf tea may be coated with theanine. However, whilst the black leaf tea provides a convenient carrier for the theanine, the coating may alter some properties of the leaf such as the appearance of the leaf. We have found that such effects can be diluted without affecting the enhanced infusion performance by blending the coated leaf with uncoated leaf. Thus in a preferred embodiment the weight ratio of coated to uncoated leaf tea in the precursor is from 1:50 to 5:1, more preferably from 1:20 to 2:1, more preferably still from 1:10 to 1:1 and most preferably from 1:5 to 1:2.
Other components:
The precursor may comprise additional components such as biopolymers (including starches and/or gums), sweeteners, acids, polyphenols, caffeine, flavours, or mixtures thereof. Particularly preferred is caffeine as this may add bitter flavour to beverages prepared from the precursor which may help to remove any unwanted taste of the theanine. Furthermore, caffeine enhances certain physiological effects of theanine. Thus in a preferred embodiment the precursor comprises caffeine. The weight ratio of theanine to caffeine is preferably in the range of 10:1 to 1:5, more preferably from 5:1 to 1:1.5.
Because enhanced infusion performance is provided by the theanine there is no need for additional infusion aids. Thus it is preferred that the precursor is free of added ascorbic acid, its salts and/or oxidation products. It is also preferred that the precursor is free from added oxidising agents. In a particularly preferred embodiment the dry matter of the beverage precursor consists of black leaf tea and theanine.
The precursor will typically comprise water. However, it is preferred that the precursor is substantially dry as theanine is especially prone to degradation in aqueous solution. Thus it is preferred that the precursor comprises less than 30% water by weight of the precursor, more preferably from 1 to 10% by weight.
Product form and packaging:
In a preferred embodiment the precursor will be in the form of a unit dose sufficient to provide a single beverage serving when infused. For example, the dry mass of the precursor may range from 1 to 5 g, more preferably from 1.5 to 3.5 g.
As the precursor comprises leaf tea it is especially preferred that it is packaged in an infusion package such as a tea bag.
In use, the beverage precursor is used to manufacture a beverage by contacting the precursor with an aqueous medium. The aqueous medium may, for example, be water, milk or a mixture thereof.
Process
Coating the leaf tea:
The process of the invention comprises the step of (i) coating black leaf tea with a composition comprising theanine to yield coated black leaf tea comprising at least 8% theanine by dry weight of the coated black tea.
The high amount of theanine in the coated black tea allows for blending the coated tea with uncoated tea using only a relatively small amount of the coated tea whilst still enhancing the infusion performance of the beverage precursor. Thus it is preferred that the coated black leaf tea comprises at least 10% theanine by dry weight of the coated black tea, more preferably at least 15%, more preferably still at least 20% and most preferably from 25 to 60%.
Some of the theanine in the coated black leaf tea will usually be naturally present in the black leaf tea. However, typically the theanine in the composition comprising theanine will make up at least 75% of the total theanine in the coated black leaf tea, more preferably at least 85%, more preferably still at least 90% and most preferably from 95 to 100%.
The composition comprising theanine may comprise synthetic theanine, such as Suntheanine™ from the Taiyo Corporation. Alternatively or additionally the composition comprising theanine may be part of a tea extract, especially a tea extract naturally enriched in theanine such as those described in international patent applications WO 2006/021317, WO 2006/037503, WO 2006/037511 and/or WO 2006/037504, which are hereby incorporated by reference in their entirety.
The amount of theanine in the composition comprising theanine may, for example, range from 5 to 100% by dry weight of the composition. It is preferred that the composition comprises at least 10% theanine by dry weight of the composition, more preferably at least 20%, more preferably still at least 50% and most preferably at least 80%. The composition may comprise additional dry components such as biopolymers (including starches and/or gums), sweeteners, acids, polyphenols, caffeine, flavours, or mixtures thereof. In a particularly preferred embodiment the composition comprises water-soluble tea solids such as caffeine, polyphenols or a mixture thereof, especially preferred is caffeine.
It is preferred that the black leaf tea is not contacted with an oxidising agent during the coating step (i) as theanine is easily degraded by oxidising agents.
Coating may be achieved in any suitable manner, however in a preferred embodiment, the black leaf tea is contacted with the composition comprising theanine in the presence of a solvent and the solvent is then removed. The preferred solvent is water which is removed by drying, preferably in a fluid bed drier as this avoids contact of the tea with hot surfaces which may lead to scorching of the tea. The amount of solvent removed is preferably sufficient that the coated black leaf tea comprises the solvent in an amount of less than 30% by weight of the coated black leaf tea, more preferably from 1 to 10%.
Where the solvent is water, the coating may be achieved, for example, by soaking the black leaf tea in an aqueous solution of the composition and/or spraying the aqueous solution onto the black leaf tea.
It is preferred that the amount of solvent is not too large as removal of large amounts of solvent would require a long time and/or large amount of energy. Thus it is preferred that the weight ratio of solvent to black leaf tea in step (i) is from 10:1 to 1:10, more preferably from 5:1 to 1:5, more preferably still from 3:1 to 1:2 and most preferably from 2:1 to 1:1.
It is preferred that the black leaf tea is agitated during the coating step (i) to allow for coating of a maximum amount of the black leaf tea.
Blending:
The process comprises the step of (ii) blending the coated black leaf tea with uncoated leaf tea. Whilst there is no limit to the proportions in which the coated black leaf tea may be blended with uncoated leaf tea, it is preferred that the coated and uncoated leaf tea are blended in a dry weight ratio of from 1:50 to 5:1, more preferably from 1:20 to 2:1, more preferably still from 1:10 to 1:1 and most preferably from 1:5 to 1:2. The uncoated leaf tea is preferably black leaf tea.
Additional Steps:
In a preferred embodiment the process comprises one or more additional steps selected from sorting the leaf tea according to size, packaging the precursor in an infusion package or a combination thereof. In a particularly preferred embodiment, the process comprises sorting the black leaf tea according to size before coating in step (i) . Sorting before coating minimises the risk of wasting theanine-rich material which could result if sorting only occurs after step (i).
The beverage precursor:
The beverage precursor recovered from the process preferably has the composition as described herein above for the precursor of the first aspect, including any or all of the preferred embodiments thereof.
EXAMPLES
The invention will be further illustrated by reference to the following non-limiting examples.
Example 1
This Example demonstrates the improvement in infusion performance obtained by adding theanine to black leaf tea.
Materials:
Black leaf tea was Lipton Yellow Label™ supplied by Unilever Foodsolutions (Crawley, UK) and had a total theanine content of about 1% by weight.
Theanine was Suntheanine™ supplied by Taiyo Kagaku (Yokkaichi, Japan) .
Sample Preparation:
Six samples were prepared with varying amounts of theanine as shown in table 1.
TABLE 1
Sample Mass of Black Mass of Theanine Theanine Content
No. Leaf Tea (g) Added

Documents

Application Documents

# Name Date
1 402-MUMNP-2010-FORM 3(10-12-2013).pdf 2013-12-10
2 402-MUMNP-2010-CORRESPONDENCE(IPO)-(HEARING NOTICE)-(06-02-2014).pdf 2014-02-06
3 402-MUMNP-2010-CORRESPONDENCE(IPO)-(FER)-(06-02-2014).pdf 2014-02-06
4 402-MUMNP-2010-FORM 3(11-11-2014).pdf 2014-11-11
5 402-MUMNP-2010-FORM 3-(25-04-2015).pdf 2015-04-25
6 402-MUMNP-2010-CORRESPONDENCE(14-08-2015).pdf 2015-08-14
7 Petition Under Rule 137 [30-12-2015(online)].pdf 2015-12-30
8 Other Document [30-12-2015(online)].pdf 2015-12-30
9 402-MUMNP-2010-FORM 2-(GRANTED)-(02-02-2016).pdf 2016-02-02
10 402-MUMNP-2010-FORM 2(TITLE PAGE)-(GRANTED)-(02-02-2016).pdf 2016-02-02
11 402-MUMNP-2010-CORRESPONDENCE(IPO)-(ORDER)-(02-02-2016).pdf 2016-02-02
12 402-MUMNP-2010-CORRESPONDENCE(IPO)-(02-02-2016).pdf 2016-02-02
13 402-MUMNP-2010-CLAIMS(GRANTED)-(02-02-2016).pdf 2016-02-02
14 402-MUMNP-2010_EXAMREPORT.pdf 2018-08-10
15 402-mumnp-2010-wo international publication report a1.pdf 2018-08-10
16 402-MUMNP-2010-REPLY TO HEARING-060116.pdf 2018-08-10
17 402-MUMNP-2010-REPLY TO EXAMINATION REPORT(10-7-2014).pdf 2018-08-10
17 402-MUMNP-2010-FORM 18(8-6-2011).pdf 2018-08-10
18 402-mumnp-2010-other document.pdf 2018-08-10
19 402-MUMNP-2010-OTHER DOCUMENT(10-7-2014).pdf 2018-08-10
20 402-MUMNP-2010-MARKED COPY-060116.pdf 2018-08-10
21 402-MUMNP-2010-GENERAL POWER OF ATTORNEY(10-7-2014).pdf 2018-08-10
22 402-mumnp-2010-form pct-isa-237.pdf 2018-08-10
23 402-mumnp-2010-form pct-isa-210.pdf 2018-08-10
24 402-mumnp-2010-form 5.pdf 2018-08-10
25 402-mumnp-2010-form 3.pdf 2018-08-10
26 402-MUMNP-2010-Form 3-071015.pdf 2018-08-10
27 402-MUMNP-2010-FORM 3(8-8-2012).pdf 2018-08-10
28 402-MUMNP-2010-FORM 3(3-8-2010).pdf 2018-08-10
29 402-MUMNP-2010-FORM 3(23-1-2013).pdf 2018-08-10
30 402-MUMNP-2010-FORM 3(22-6-2013).pdf 2018-08-10
31 402-MUMNP-2010-FORM 3(21-5-2014).pdf 2018-08-10
32 402-MUMNP-2010-FORM 3(18-2-2011).pdf 2018-08-10
33 402-MUMNP-2010-FORM 3(16-8-2011).pdf 2018-08-10
34 402-MUMNP-2010-FORM 3(13-2-2012).pdf 2018-08-10
35 402-mumnp-2010-form 2.pdf 2018-08-10
36 402-mumnp-2010-form 2(title page).pdf 2018-08-10
37 402-MUMNP-2010-FORM 18(8-6-2011).pdf 2018-08-10
38 402-MUMNP-2010-FORM 13(8-2-2012).pdf 2018-08-10
39 402-mumnp-2010-form 1.pdf 2018-08-10
40 402-mumnp-2010-description(complete).pdf 2018-08-10
41 402-mumnp-2010-correspondence.pdf 2018-08-10
42 402-MUMNP-2010-Correspondence-281215.pdf 2018-08-10
43 402-MUMNP-2010-Correspondence-090216.pdf 2018-08-10
44 402-MUMNP-2010-CORRESPONDENCE(8-6-2011).pdf 2018-08-10
45 402-mumnp-2010-claims.pdf 2018-08-10
46 402-MUMNP-2010-Claims-060116.pdf 2018-08-10
47 402-MUMNP-2010-CLAIMS(MARKED COPY)-(10-7-2014).pdf 2018-08-10
48 402-MUMNP-2010-CLAIMS(AMENDED)-(10-7-2014).pdf 2018-08-10
49 402-MUMNP-2010-ANNEXURE TO FORM 3(10-7-2014).pdf 2018-08-10
50 402-MUMNP-2010-RELEVANT DOCUMENTS [09-09-2021(online)].pdf 2021-09-09
51 402-MUMNP-2010-RELEVANT DOCUMENTS [15-09-2022(online)].pdf 2022-09-15
52 402-MUMNP-2010-RELEVANT DOCUMENTS [29-09-2023(online)].pdf 2023-09-29
53 402-MUMNP-2010-FORM-27 [28-08-2024(online)].pdf 2024-08-28

ERegister / Renewals

3rd: 27 Apr 2016

From 06/08/2010 - To 06/08/2011

4th: 27 Apr 2016

From 06/08/2011 - To 06/08/2012

5th: 27 Apr 2016

From 06/08/2012 - To 06/08/2013

6th: 27 Apr 2016

From 06/08/2013 - To 06/08/2014

7th: 27 Apr 2016

From 06/08/2014 - To 06/08/2015

8th: 27 Apr 2016

From 06/08/2015 - To 06/08/2016

9th: 27 Apr 2016

From 06/08/2016 - To 06/08/2017

10th: 03 Aug 2017

From 06/08/2017 - To 06/08/2018

11th: 06 Aug 2018

From 06/08/2018 - To 06/08/2019

12th: 01 Aug 2019

From 06/08/2019 - To 06/08/2020

13th: 28 Jul 2020

From 06/08/2020 - To 06/08/2021

14th: 11 Aug 2021

From 06/08/2021 - To 06/08/2022

15th: 04 Aug 2022

From 06/08/2022 - To 06/08/2023

16th: 04 Aug 2023

From 06/08/2023 - To 06/08/2024

17th: 01 Jul 2024

From 06/08/2024 - To 06/08/2025

18th: 30 Jul 2025

From 06/08/2025 - To 06/08/2026